William Ashton - Jun 17, 2021 Form 4 Insider Report for SPECTRUM PHARMACEUTICALS INC (SPPI)

Role
Director
Signature
/s/ Kurt A. Gustafson, attorney-in-fact for William L. Ashton
Stock symbol
SPPI
Transactions as of
Jun 17, 2021
Transactions value $
-$38,160
Form type
4
Date filed
6/22/2021, 04:51 PM
Previous filing
May 17, 2021
Next filing
May 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPPI Common Stock, $0.001 par value Award $0 +14.3K +34.27% $0.00 55.9K Jun 17, 2021 Direct F1
transaction SPPI Common Stock, $0.001 par value Sale -$38.2K -9K -16.09% $4.24 46.9K Jun 18, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPPI Stock Option (Right to Buy) Award $0 +67.8K $0.00 67.8K Jun 17, 2021 Common Stock 67.8K $4.29 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the restricted shares shall vest on the earlier of (1) June 17, 2022 or (2) the date of the company's 2022 Annual Meeting of Stockholders.
F2 All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
F3 One third of the aggregate amount of option shares shall vest on each of June 17, 2022, 2023 and 2024, respectively.